Recombinant Human GNAQ Protein: Handling & Usage Protocol

Recombinant Human GNAQ Protein is a purified G-protein alpha subunit used in signal transduction research, offering a reliable tool for studying phospholipase C activation, GTPase activity, and downstream second-messenger pathways.

Product Name

Recombinant Human GNAQ Protein

SKU

rp371625

Protein Function

Gq-family alpha subunit; activates phospholipase C-beta and regulates intracellular calcium signaling

Recommended Storage

-80°C for long-term storage; avoid repeated freeze-thaw cycles

Primary Applications

GTPase activity assays, protein-protein interaction studies, signal transduction pathway research

Host / Expression System

Refer to product datasheet (rp371625) for confirmed expression system details

Background and Biological Significance of GNAQ

GNAQ (Guanine Nucleotide-binding protein G(q) subunit alpha) is a member of the Gq/11 family of heterotrimeric G-protein alpha subunits. Upon activation by G-protein-coupled receptors (GPCRs), GNAQ exchanges GDP for GTP and dissociates from the beta-gamma dimer, subsequently activating phospholipase C-beta (PLC-β). This leads to hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) into inositol trisphosphate (IP3) and diacylglycerol (DAG), which mobilize intracellular calcium stores and activate protein kinase C (PKC), respectively.

GNAQ is widely studied in the context of uveal melanoma, where activating mutations at codon 209 (Q209L) or codon 183 (R183C) are found in the majority of cases, rendering the protein constitutively active. Research-grade recombinant GNAQ protein (SKU: rp371625) enables biochemical characterization of wild-type and mutant forms, supporting drug discovery, structural biology, and mechanistic studies.

Materials and Equipment Required

Before beginning, ensure the following materials and equipment are available:

• Recombinant Human GNAQ Protein (rp371625, Aladdin Scientific)
• Sterile, nuclease-free deionized water or manufacturer-recommended reconstitution buffer (see product datasheet)
• Microcentrifuge tubes (low-protein-binding, 1.5 mL)
• Calibrated micropipettes and sterile tips
• Refrigerated microcentrifuge
• Dry ice or liquid nitrogen for snap-freezing aliquots
• -80°C ultra-low temperature freezer
• Spectrophotometer or BCA/Bradford assay reagents for protein concentration verification
• Relevant assay-specific reagents (e.g., GTPase assay kit, pull-down beads, ELISA components)

Note: Always consult the current product datasheet (rp371625) for lot-specific buffer composition, protein concentration, purity data, and recommended working concentrations before proceeding.

Step-by-Step Reconstitution and Handling Protocol

Step 1 – Thawing: Transfer the vial from -80°C storage and allow it to thaw on ice (4°C) for 10–15 minutes. Do not thaw at room temperature or in a water bath, as this may compromise protein integrity and GTPase activity.

Step 2 – Brief centrifugation: Gently centrifuge the vial at 1,000–2,000 × g for 30 seconds to collect any condensed material from the walls and cap.

Step 3 – Reconstitution (if lyophilized): If the product is supplied in lyophilized form, add the volume of sterile reconstitution buffer specified in the datasheet slowly along the wall of the vial. Do not vortex. Gently pipette up and down or allow to dissolve at 4°C with gentle rotation for 10 minutes.

Step 4 – Protein concentration verification: Measure protein concentration using a BCA or Bradford assay against a BSA standard curve, or by absorbance at 280 nm if the extinction coefficient is provided in the datasheet.

Step 5 – Aliquoting: Prepare single-use aliquots appropriate for your assay volume to avoid repeated freeze-thaw cycles. Use low-protein-binding tubes. Snap-freeze aliquots in liquid nitrogen or on dry ice before transferring to -80°C storage.

Step 6 – Quality check: Prior to critical experiments, verify protein integrity by SDS-PAGE and, where applicable, confirm GTPase activity using a malachite green or NADH-coupled GTPase assay.

Step 7 – Working conditions: Maintain protein on ice throughout all manipulations. Minimize exposure to repeated temperature fluctuations. Follow the working concentration ranges recommended in the product datasheet for each specific application.

Application Notes and Downstream Assay Compatibility

Recombinant Human GNAQ Protein (rp371625) is suitable for a range of biochemical and cell-free applications. Typical uses include:

• GTPase Activity Assays: GNAQ exhibits intrinsic GTPase activity. Malachite green phosphate detection or NADH-coupled enzyme assays can be used to measure the rate of GTP hydrolysis. Ensure that assay buffers are compatible (typically containing MgCl2 and appropriate reducing agents such as DTT).
• Protein–Protein Interaction Studies: Use in pull-down, co-immunoprecipitation, or SPR/BLI assays to study interactions with RGS proteins, PLC-β isoforms, and GPCR-derived peptides.
• Structural and Biophysical Studies: Suitable as a component in crystallography, cryo-EM sample preparation, or thermofluor stability assays.
• Inhibitor Screening: Applicable in high-throughput screening formats to identify small-molecule modulators of GNAQ GTPase activity or protein–protein interactions.

Buffer compatibility: Verify that assay buffers do not contain components that interfere with GTP binding (e.g., high EDTA concentrations that chelate Mg2+ essential for GTPase function). Refer to current literature and the product datasheet for validated buffer conditions.

Troubleshooting and Quality Control

The following troubleshooting guidance addresses common issues encountered when working with recombinant GNAQ protein:

Issue	Possible Cause	Recommended Action
Low or no GTPase activity	Protein degradation due to improper thawing or storage	Use freshly thawed aliquots; verify storage at -80°C; check for protein integrity by SDS-PAGE
Protein precipitation	Freeze-thaw damage or incompatible buffer	Spin at 10,000 × g for 5 min at 4°C to remove aggregates; avoid vortexing; use recommended buffer
Inconsistent assay results	Variable working concentrations or pipetting errors	Prepare a fresh master mix; re-verify concentration by BCA/Bradford; use calibrated pipettes
Unexpected bands on SDS-PAGE	Protein degradation or contaminants	Compare to expected MW from datasheet; contact Aladdin Scientific technical support with lot number

For persistent technical issues, please contact Aladdin Scientific technical support, providing the product SKU (rp371625), lot number, and a description of the experimental conditions.

Frequently asked questions

What is the recommended storage condition for Recombinant Human GNAQ Protein (rp371625)?

Recombinant Human GNAQ Protein should be stored at -80°C for long-term preservation. Aliquot the protein into single-use volumes before freezing to avoid repeated freeze-thaw cycles, which can lead to loss of activity and protein aggregation. Always consult the product datasheet for lot-specific storage instructions.

What applications is Recombinant Human GNAQ Protein suitable for?

Recombinant Human GNAQ Protein (rp371625) is suitable for GTPase activity assays, protein–protein interaction studies (pull-down, co-IP, SPR/BLI), structural and biophysical analyses, and small-molecule inhibitor screening. Please refer to the product datasheet for validated application conditions and recommended working concentrations.

How should I reconstitute lyophilized Recombinant Human GNAQ Protein?

If supplied in lyophilized form, add the volume of sterile reconstitution buffer specified in the product datasheet slowly along the inner wall of the vial. Do not vortex. Allow the protein to dissolve by gentle pipetting or slow rotation at 4°C for approximately 10 minutes, then briefly centrifuge before use. Confirm the final protein concentration using a BCA or Bradford assay.

Why is it important to avoid EDTA in GTPase assay buffers when using GNAQ protein?

GNAQ GTPase activity requires the presence of Mg2+ ions, which coordinate with GTP in the active site to facilitate hydrolysis. EDTA is a chelating agent that sequesters divalent cations including Mg2+, thereby inhibiting GTPase activity. Assay buffers should therefore contain MgCl2 and exclude or minimize EDTA to preserve enzymatic function.

How can I verify the quality and activity of Recombinant Human GNAQ Protein before use?

Protein integrity can be assessed by SDS-PAGE under reducing conditions, comparing the observed band to the expected molecular weight listed in the product datasheet. GTPase activity can be confirmed using a malachite green phosphate detection assay or an NADH-coupled GTPase activity assay. Contact Aladdin Scientific technical support if results deviate significantly from expected specifications.

References

1. Bhatt DL, et al. GNAQ and GNA11 mutations in uveal melanoma: biological significance and therapeutic implications. (General reference; verify specific authors, journal, and year from primary literature.)
2. Simon MI, Strathmann MP, Gautam N. Diversity of G proteins in signal transduction. Science. 1991;252(5007):802-808. PMID:1902986
3. Offermanns S. G proteins as transducers in transmembrane signalling. Prog Biophys Mol Biol. 2003;83(2):101-130. PMID:12865074
4. Van Raamsdonk CD, et al. Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature. 2009;457(7229):599-602. doi:10.1038/nature07586

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.